Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
Clinical trial NCT01353027 · COMPLETED
Trial details
- NCT number
- NCT01353027
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.